West Pharmaceutical
213 hedge funds and large institutions have $2.96B invested in West Pharmaceutical in 2014 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 83 reducing their positions, and 31 closing their positions.
129% more call options, than puts
Call options by funds: $112K | Put options by funds: $49K
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
8% more capital invested
Capital invested by funds: $2.74B → $2.96B (+$220M)
1.52% more ownership
Funds ownership: 91.96% → 93.48% (+1.5%)
7% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 83
4% less funds holding
Funds holding: 222 → 213 (-9)
13% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
+$28.5M |
| 2 |
HIM
Hermes Investment Management
London Uk,
United Kingdom
|
+$24.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.7M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$13.5M |
| 5 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
+$13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$15.9M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
-$15.4M |
| 3 |
Renaissance Technologies
New York
|
-$15.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$13.9M |
| 5 |
Morgan Stanley
New York
|
-$8.54M |
WST Hedge Fund Activity: Q3 2014 in Review
213 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2014, worth a combined $2.96B — up 8% from $2.74B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of WST and 27 opened new positions — a net loss of 4 holders — while 83 trimmed existing stakes and 77 added.
The largest buyer was BAMCO Inc, adding an estimated $28.5M. The largest seller was Norges Bank, cutting an estimated $15.9M.
- 213 institutional investors held West Pharmaceutical (WST) as of Q3 2014, down from 222 in Q2 2014.
- Funds reported $2.96B of West Pharmaceutical stock for Q3 2014, up 8% quarter-over-quarter.
- 27 funds opened new West Pharmaceutical positions in Q3 2014 and 31 closed out, a net change of -4 holders.
- The largest West Pharmaceutical buyer in Q3 2014 was BAMCO Inc, an estimated $28.5M added.
- The largest West Pharmaceutical seller in Q3 2014 was Norges Bank, an estimated $15.9M sold.
Based on aggregated 13F filings for Q3 2014.